Clinical Trial

Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars

Study acronym: OXY - MTA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate clinical and radiographic success of oxymetazoline versus sodium hypochlorite as hemostatic agents in MTA pulpotomy of primary molars.
Trial Details
NCT Number NCT07675330
Lead Sponsor Cairo University
Conditions Pulp Disease, Dental, Pulp Therapy in Primary Molars, Pulpitis - Reversible, Pulp Inflammation, Vital Pulp Therapies, Carious Exposure of Pulp, Primary Molar Tooth, Primary Molar Pulpotomy
Enrollment 50 participants
Start Date 2026-08
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-30